Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.
Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.


RARE DISEASE
Caffey disease
Caffey disease
Caffey disease
Synonyms: Infantile cortical hyperostosis
Synonyms: Infantile cortical hyperostosis
Synonyms: Infantile cortical hyperostosis
Drug discovery
18
papers
On emerging therapies
Rare bone diseases
Caffey disease
Overview
Caffey disease (infantile cortical hyperostosis) is a rare, self-limiting osteosclerotic dysplasia characterized by acute inflammation, subperiosteal new bone formation, and soft tissue swelling, typically affecting infants ≤5 months old [1][5][8]. Key features include fever, irritability, mandibular/clavicular hyperostosis, and cortical thickening of long bones, ribs, or scapulae. Autosomal dominant COL1A1 mutations (e.g., R836C) underlie familial cases, though sporadic forms exist [1][5]. Diagnosis relies on clinical presentation, radiography, and exclusion of mimics (e.g., osteomyelitis, child abuse). Management includes NSAIDs/corticosteroids for symptom control, with spontaneous resolution by age 2 in most cases [2][6][8]. Prenatal forms may be lethal [1].
Therapies
Categories: rare bone diseases, rare developmental anomalies during embryogenesis, rare genetic diseases
Research Papers
18 drug discovery papers about Caffey disease. Recent publications:
18 drug discovery papers about Caffey disease. Recent publications:
categories:
Small molecules
small molecules
2023-12-28 | Congenital cortical hyperostosis: a rare cause of inconsolable crying in a baby. Clinical case report
Here we describe the case of a 2-month-old infant who consulted several times due to excessive crying, initially interpreted as having a gastrointestinal cause. Since the symptom persisted, a fracture was suspected due to its association with mobilization of the limbs and palpation of a mass on the anterior aspect of the right tibia. X-rays showed diaphyseal polyostotic involvement and lesions compatible with cortical involvement of long bones. Caffey-De Toni-Silverman syndrome was diagnosed and treatment with nonsteroidal anti-inflammatory drugs was initiated, resulting in symptom remission. Subsequently, the diagnosis was confirmed by the identification of the pathogenic heterozygous variant COL1A1. This is a rare condition with an estimated incidence of 48/100 000 individuals, and less than 150 cases have been described to date.
2020-08-01 | INFANT WITH MANDIBULAR SWELLING: A CASE OF INFANTILE CORTICAL HYPEROSTOSIS
A 6-month-old girl had been having intermittent febrile episodes for 2 months for which she had received multiple antimicrobials for presumed bacterial infections. A month later, mother noticed slowly progressing swelling of both cheeks and tenderness in jaw and submandibular area. At examination, she was active and with good general well-being. There was diffuse mandibular swelling, warm tender and associated with submandibular cervical lymphadenopathy (Fig. 1). Systemic examination was unremarkable. A clinical possibility of suppurative lymphadenitis was made and initiated on intravenous ceftriaxone. Investigations showed haemoglobin 91 g/L; leukocyte count 15.4 × 109/L; differential count polymorphs 34%, lymphocyte 55%, monocyte 10% and eosinophils 1%; platelet count 633 × 109/L; C-reactive protein 72 mg/L (n < 6 mg/L) and erythrocyte sedimentation rate 60 mm/h. Serum procalcitonin was 0.04 (n < 0.5 ng/mL). Blood and urine cultures were sterile. Tuberculin test was negative and chest X-ray was unremarkable. Ultrasonograph neck revealed bilateral cervical lymphadenopathy with intraparotid enlarged nodes. Despite intravenous antibiotics, child continued to be symptomatic. Clinical possibility of inflammatory bone disease like infantile cortical hyperosteosis was considered as she had predominant mandibular symptoms, remained active despite high inflammatory parameters with no response to antibiotics. X-ray mandible showed hyperostosis but no periosteal reaction (Fig. 2). Bone scintigraphy with Technetium 99m isotope was performed which showed intense radiotracer uptake in whole of mandible, also called the ‘Bearded baby appearance’, consistent with Caffey's disease. The absence of focal areas and periosteal elevations ruled out osteomyelitis (Fig. 3). Rest of the skeleton was normal without any tracer uptake. She was commenced on oral prednisolone (2 mg/kg/day) and antibiotics were stopped. Over the next 72 h, child improved dramatically, swelling decreased significantly and inflammatory markers normalised. The patient was discharged on oral prednisolone which was gradually tapered and stopped over next 4 weeks. Infantile cortical hyperostosis was first reported in 1945 and later described by John Caffey in 1956, leading to the name Caffey Disease.1 Young infants less than 6 months of age with infantile cortical hyperostosis present with fever, irritability and tender soft tissue swellings showing hyperostosis on radiography. Although the condition is usually self-limiting, corticosteroids and anti-inflammatory drugs have been tried successfully in reducing the duration of illness.2 Caffey disease has often been found to mimic bacterial osteomyelitis, which was a differential in index case also. However, prolonged course, active child, lymphocytic predominance in leucocyte count, negative procalcitonin, no response to antimicrobials were odd for osteomyelitis. Characteristic radiology and nuclear scintigraphy of mandible coupled with response to corticosteroids confirms the diagnosis of Caffey disease.3, 4 Although multiple bones are usually affected in Caffey disease and mandible is the most common site of involvement, isolated mandibular involvement has rarely been described.2, 5
2019-09-18 | Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Wnt signaling plays a key role in regulating bone remodeling. In vitro studies suggest that sclerostin's inhibitory action on Lrp5 is facilitated by the membrane-associated receptor Lrp4. We generated an Lrp4 R1170W knockin mouse model (Lrp4KI), based on a published mutation in patients with high bone mass (HBM). Lrp4KI mice have an HBM phenotype (assessed radiographically), including increased bone strength and formation. Overexpression of a Sost transgene had osteopenic effects in Lrp4-WT but not Lrp4KI mice. Conversely, sclerostin inhibition had blunted osteoanabolic effects in Lrp4KI mice. In a disuse-induced bone wasting model, Lrp4KI mice exhibit significantly less bone loss than wild-type (WT) mice. In summary, mice harboring the Lrp4-R1170W missense mutation recapitulate the human HBM phenotype, are less sensitive to altered sclerostin levels, and are protected from disuse-induced bone loss. Lrp4 is an attractive target for pharmacological targeting aimed at increasing bone mass and preventing bone loss due to disuse.
2017-03-01 | Infantile cortical hyperostosis presenting as painful bilateral swelling of the mandible
Infantile cortical hyperostosis (ICH) is a rare inflammatory condition of unknown aetiology and histogenesis. It is characterised by unusual irritability, soft tissue swelling and cortical hyperostosis affecting multiple bones. In this poster, we are reporting a case of an eight-week-old boy presenting with painful bilateral mandibular swelling and irritability. The patient had history of neonatal sepsis that was managed with intravenous antibiotics with good recovery. Clinical examination showed irritable child with tenderness and erythematous swelling over bilateral angles of mandible with no detectable oral infection. Facial computed tomography showed extensive inflammation of bilateral masseter muscles, intraosseous hypodensity of mandibular angles and rami with diffuse subperiosteal reaction. Mandibular osteomyelitis was suspected and biopsy of involved bone and soft tissues was conducted. Microbiology result was negative for microorganisms and the histopathology report did not show any bone necrosis. Full skeletal survey showed periosteal cortical thickening of the mandible, left clavicle and scapula, bilateral leg and forearm bones confirming the diagnosis of ICH. The patient had a four-week course of prednisolone with marked improvement. A nine months review showed resolution of the facial swellings and pain. This poster highlights that the awareness of this condition may permit earlier recognition and less intensive diagnostic workup.
2008-11-01 | Effects of Iloprost on Calvarial Sutures
Premature fusion of calvarial sutures is the result of a long and complex reaction, and several growth factors including transforming growth factor β and basic fibroblast growth factor have important role in this event. Several prostaglandins have important functions in local bone modeling and remodeling by autocrine and paracrine mechanisms. Although effects of prostaglandins on long bones were studied both experimentally and clinically, there are limited data about cranial bones and sutures. In this study, we investigated the effect of iloprost-a stable prostacyclin analogue, which is widely used for the treatment of pulmonary arterial hypertension even in early pregnancy, to rat calvarial sutures. In 2 study groups, iloprost was injected intraperitoneally 10 and 15 μg kg−1 d−1, respectively. In the third group, dexamethasone 2 mg kg−1 d−1 + iloprost 15 μg kg−1 d−1 was injected intraperitoneally to antagonize the effects of iloprost. In every group, 4 rats were killed at the postoperative 15, 30, and 45 days, and specimens including the sagittal and frontal sutures were excised immediately. Routine histological and immunohistological staining were performed on the specimens. Morphological measurements were performed on the skulls, also. In histological evaluation, bone formation in the both frontal and sagittal suture area was increased and accelerated in iloprost groups. Dexamethasone inhibited the effects of iloprost on the third group. Expressions of transforming growth factor β and basic fibroblast growth factor were also increased in immunohistological staining. In morphological measurements, statistically significant differences were found between control and study groups. Iloprost did not fused the rat calvarial sutures prematurely, but it narrowed the sagittal and frontal sutures especially after the second week of the study. This situation might effect the sutures of the babies of the pregnant patients with pulmonary arterial hypertension treated with iloprost. Cranial sutures, calvarial bones, and cranial shape of the babies of the pregnant patients who were treated with iloprost should be monitored to clarify the topic.
gene therapies
2023-08-30 | Col1a2-Deleted Mice Have Defective Type I Collagen and Secondary Reactive Cardiac Fibrosis with Altered Hypertrophic Dynamics
Rationale: The adult cardiac extracellular matrix (ECM) is largely comprised of type I collagen. In addition to serving as the primary structural support component of the cardiac ECM, type I collagen also provides an organizational platform for other ECM proteins, matricellular proteins, and signaling components that impact cellular stress sensing in vivo. Objective: Here we investigated how the content and integrity of type I collagen affect cardiac structure function and response to injury. Methods and Results: We generated and characterized Col1a2−/− mice using standard gene targeting. Col1a2−/− mice were viable, although by young adulthood their hearts showed alterations in ECM mechanical properties, as well as an unanticipated activation of cardiac fibroblasts and induction of a progressive fibrotic response. This included augmented TGFβ activity, increases in fibroblast number, and progressive cardiac hypertrophy, with reduced functional performance by 9 months of age. Col1a2-loxP-targeted mice were also generated and crossed with the tamoxifen-inducible Postn-MerCreMer mice to delete the Col1a2 gene in myofibroblasts with pressure overload injury. Interestingly, while germline Col1a2−/− mice showed gradual pathologic hypertrophy and fibrosis with aging, the acute deletion of Col1a2 from activated adult myofibroblasts showed a loss of total collagen deposition with acute cardiac injury and an acute reduction in pressure overload-induce cardiac hypertrophy. However, this reduction in hypertrophy due to myofibroblast-specific Col1a2 deletion was lost after 2 and 6 weeks of pressure overload, as fibrotic deposition accumulated. Conclusions: Defective type I collagen in the heart alters the structural integrity of the ECM and leads to cardiomyopathy in adulthood, with fibroblast expansion, activation, and alternate fibrotic ECM deposition. However, acute inhibition of type I collagen production can have an anti-fibrotic and anti-hypertrophic effect.
2020-05-17 | Dynamic protein quantitation (DyProQ) of procollagen-I by CRISPR-Cas9 NanoLuciferase tagging
The ability to quantitate a protein of interest temporally and spatially at subcellular resolution in living cells would generate new opportunities for research and drug discovery but remains a major technical challenge. Here, we describe dynamic protein quantitation (DyProQ) which is effective across microscopy and multiwell platforms. Using collagen as a test protein, CRISPR-Cas9-mediated introduction of nluc (encoding NanoLuciferase, NLuc) into the Col1a2 locus enabled simplification and miniaturisation of procollagen-I (PC-I) quantitation. We robustly assessed extracellular, intracellular, and subcellular PC-I levels, by correlating to known concentrations of recombinant NLuc in the presence of substrate. Loss of collagen causes tissue degeneration whereas excess collagen results in fibrosis (often with poor-outcome) and is evident in aggressive cancers; however, treatment options are extremely limited. Using collagen-DyProQ, we screened a library of 1,971 FDA-approved compounds and identified 10 candidates for repurposing in the treatment of fibrotic and 7 for degenerative diseases.
small molecules
2023-12-28 | Congenital cortical hyperostosis: a rare cause of inconsolable crying in a baby. Clinical case report
Here we describe the case of a 2-month-old infant who consulted several times due to excessive crying, initially interpreted as having a gastrointestinal cause. Since the symptom persisted, a fracture was suspected due to its association with mobilization of the limbs and palpation of a mass on the anterior aspect of the right tibia. X-rays showed diaphyseal polyostotic involvement and lesions compatible with cortical involvement of long bones. Caffey-De Toni-Silverman syndrome was diagnosed and treatment with nonsteroidal anti-inflammatory drugs was initiated, resulting in symptom remission. Subsequently, the diagnosis was confirmed by the identification of the pathogenic heterozygous variant COL1A1. This is a rare condition with an estimated incidence of 48/100 000 individuals, and less than 150 cases have been described to date.
2020-08-01 | INFANT WITH MANDIBULAR SWELLING: A CASE OF INFANTILE CORTICAL HYPEROSTOSIS
A 6-month-old girl had been having intermittent febrile episodes for 2 months for which she had received multiple antimicrobials for presumed bacterial infections. A month later, mother noticed slowly progressing swelling of both cheeks and tenderness in jaw and submandibular area. At examination, she was active and with good general well-being. There was diffuse mandibular swelling, warm tender and associated with submandibular cervical lymphadenopathy (Fig. 1). Systemic examination was unremarkable. A clinical possibility of suppurative lymphadenitis was made and initiated on intravenous ceftriaxone. Investigations showed haemoglobin 91 g/L; leukocyte count 15.4 × 109/L; differential count polymorphs 34%, lymphocyte 55%, monocyte 10% and eosinophils 1%; platelet count 633 × 109/L; C-reactive protein 72 mg/L (n < 6 mg/L) and erythrocyte sedimentation rate 60 mm/h. Serum procalcitonin was 0.04 (n < 0.5 ng/mL). Blood and urine cultures were sterile. Tuberculin test was negative and chest X-ray was unremarkable. Ultrasonograph neck revealed bilateral cervical lymphadenopathy with intraparotid enlarged nodes. Despite intravenous antibiotics, child continued to be symptomatic. Clinical possibility of inflammatory bone disease like infantile cortical hyperosteosis was considered as she had predominant mandibular symptoms, remained active despite high inflammatory parameters with no response to antibiotics. X-ray mandible showed hyperostosis but no periosteal reaction (Fig. 2). Bone scintigraphy with Technetium 99m isotope was performed which showed intense radiotracer uptake in whole of mandible, also called the ‘Bearded baby appearance’, consistent with Caffey's disease. The absence of focal areas and periosteal elevations ruled out osteomyelitis (Fig. 3). Rest of the skeleton was normal without any tracer uptake. She was commenced on oral prednisolone (2 mg/kg/day) and antibiotics were stopped. Over the next 72 h, child improved dramatically, swelling decreased significantly and inflammatory markers normalised. The patient was discharged on oral prednisolone which was gradually tapered and stopped over next 4 weeks. Infantile cortical hyperostosis was first reported in 1945 and later described by John Caffey in 1956, leading to the name Caffey Disease.1 Young infants less than 6 months of age with infantile cortical hyperostosis present with fever, irritability and tender soft tissue swellings showing hyperostosis on radiography. Although the condition is usually self-limiting, corticosteroids and anti-inflammatory drugs have been tried successfully in reducing the duration of illness.2 Caffey disease has often been found to mimic bacterial osteomyelitis, which was a differential in index case also. However, prolonged course, active child, lymphocytic predominance in leucocyte count, negative procalcitonin, no response to antimicrobials were odd for osteomyelitis. Characteristic radiology and nuclear scintigraphy of mandible coupled with response to corticosteroids confirms the diagnosis of Caffey disease.3, 4 Although multiple bones are usually affected in Caffey disease and mandible is the most common site of involvement, isolated mandibular involvement has rarely been described.2, 5
2019-09-18 | Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Wnt signaling plays a key role in regulating bone remodeling. In vitro studies suggest that sclerostin's inhibitory action on Lrp5 is facilitated by the membrane-associated receptor Lrp4. We generated an Lrp4 R1170W knockin mouse model (Lrp4KI), based on a published mutation in patients with high bone mass (HBM). Lrp4KI mice have an HBM phenotype (assessed radiographically), including increased bone strength and formation. Overexpression of a Sost transgene had osteopenic effects in Lrp4-WT but not Lrp4KI mice. Conversely, sclerostin inhibition had blunted osteoanabolic effects in Lrp4KI mice. In a disuse-induced bone wasting model, Lrp4KI mice exhibit significantly less bone loss than wild-type (WT) mice. In summary, mice harboring the Lrp4-R1170W missense mutation recapitulate the human HBM phenotype, are less sensitive to altered sclerostin levels, and are protected from disuse-induced bone loss. Lrp4 is an attractive target for pharmacological targeting aimed at increasing bone mass and preventing bone loss due to disuse.
2017-03-01 | Infantile cortical hyperostosis presenting as painful bilateral swelling of the mandible
Infantile cortical hyperostosis (ICH) is a rare inflammatory condition of unknown aetiology and histogenesis. It is characterised by unusual irritability, soft tissue swelling and cortical hyperostosis affecting multiple bones. In this poster, we are reporting a case of an eight-week-old boy presenting with painful bilateral mandibular swelling and irritability. The patient had history of neonatal sepsis that was managed with intravenous antibiotics with good recovery. Clinical examination showed irritable child with tenderness and erythematous swelling over bilateral angles of mandible with no detectable oral infection. Facial computed tomography showed extensive inflammation of bilateral masseter muscles, intraosseous hypodensity of mandibular angles and rami with diffuse subperiosteal reaction. Mandibular osteomyelitis was suspected and biopsy of involved bone and soft tissues was conducted. Microbiology result was negative for microorganisms and the histopathology report did not show any bone necrosis. Full skeletal survey showed periosteal cortical thickening of the mandible, left clavicle and scapula, bilateral leg and forearm bones confirming the diagnosis of ICH. The patient had a four-week course of prednisolone with marked improvement. A nine months review showed resolution of the facial swellings and pain. This poster highlights that the awareness of this condition may permit earlier recognition and less intensive diagnostic workup.
2008-11-01 | Effects of Iloprost on Calvarial Sutures
Premature fusion of calvarial sutures is the result of a long and complex reaction, and several growth factors including transforming growth factor β and basic fibroblast growth factor have important role in this event. Several prostaglandins have important functions in local bone modeling and remodeling by autocrine and paracrine mechanisms. Although effects of prostaglandins on long bones were studied both experimentally and clinically, there are limited data about cranial bones and sutures. In this study, we investigated the effect of iloprost-a stable prostacyclin analogue, which is widely used for the treatment of pulmonary arterial hypertension even in early pregnancy, to rat calvarial sutures. In 2 study groups, iloprost was injected intraperitoneally 10 and 15 μg kg−1 d−1, respectively. In the third group, dexamethasone 2 mg kg−1 d−1 + iloprost 15 μg kg−1 d−1 was injected intraperitoneally to antagonize the effects of iloprost. In every group, 4 rats were killed at the postoperative 15, 30, and 45 days, and specimens including the sagittal and frontal sutures were excised immediately. Routine histological and immunohistological staining were performed on the specimens. Morphological measurements were performed on the skulls, also. In histological evaluation, bone formation in the both frontal and sagittal suture area was increased and accelerated in iloprost groups. Dexamethasone inhibited the effects of iloprost on the third group. Expressions of transforming growth factor β and basic fibroblast growth factor were also increased in immunohistological staining. In morphological measurements, statistically significant differences were found between control and study groups. Iloprost did not fused the rat calvarial sutures prematurely, but it narrowed the sagittal and frontal sutures especially after the second week of the study. This situation might effect the sutures of the babies of the pregnant patients with pulmonary arterial hypertension treated with iloprost. Cranial sutures, calvarial bones, and cranial shape of the babies of the pregnant patients who were treated with iloprost should be monitored to clarify the topic.
gene therapies
2023-08-30 | Col1a2-Deleted Mice Have Defective Type I Collagen and Secondary Reactive Cardiac Fibrosis with Altered Hypertrophic Dynamics
Rationale: The adult cardiac extracellular matrix (ECM) is largely comprised of type I collagen. In addition to serving as the primary structural support component of the cardiac ECM, type I collagen also provides an organizational platform for other ECM proteins, matricellular proteins, and signaling components that impact cellular stress sensing in vivo. Objective: Here we investigated how the content and integrity of type I collagen affect cardiac structure function and response to injury. Methods and Results: We generated and characterized Col1a2−/− mice using standard gene targeting. Col1a2−/− mice were viable, although by young adulthood their hearts showed alterations in ECM mechanical properties, as well as an unanticipated activation of cardiac fibroblasts and induction of a progressive fibrotic response. This included augmented TGFβ activity, increases in fibroblast number, and progressive cardiac hypertrophy, with reduced functional performance by 9 months of age. Col1a2-loxP-targeted mice were also generated and crossed with the tamoxifen-inducible Postn-MerCreMer mice to delete the Col1a2 gene in myofibroblasts with pressure overload injury. Interestingly, while germline Col1a2−/− mice showed gradual pathologic hypertrophy and fibrosis with aging, the acute deletion of Col1a2 from activated adult myofibroblasts showed a loss of total collagen deposition with acute cardiac injury and an acute reduction in pressure overload-induce cardiac hypertrophy. However, this reduction in hypertrophy due to myofibroblast-specific Col1a2 deletion was lost after 2 and 6 weeks of pressure overload, as fibrotic deposition accumulated. Conclusions: Defective type I collagen in the heart alters the structural integrity of the ECM and leads to cardiomyopathy in adulthood, with fibroblast expansion, activation, and alternate fibrotic ECM deposition. However, acute inhibition of type I collagen production can have an anti-fibrotic and anti-hypertrophic effect.
2020-05-17 | Dynamic protein quantitation (DyProQ) of procollagen-I by CRISPR-Cas9 NanoLuciferase tagging
The ability to quantitate a protein of interest temporally and spatially at subcellular resolution in living cells would generate new opportunities for research and drug discovery but remains a major technical challenge. Here, we describe dynamic protein quantitation (DyProQ) which is effective across microscopy and multiwell platforms. Using collagen as a test protein, CRISPR-Cas9-mediated introduction of nluc (encoding NanoLuciferase, NLuc) into the Col1a2 locus enabled simplification and miniaturisation of procollagen-I (PC-I) quantitation. We robustly assessed extracellular, intracellular, and subcellular PC-I levels, by correlating to known concentrations of recombinant NLuc in the presence of substrate. Loss of collagen causes tissue degeneration whereas excess collagen results in fibrosis (often with poor-outcome) and is evident in aggressive cancers; however, treatment options are extremely limited. Using collagen-DyProQ, we screened a library of 1,971 FDA-approved compounds and identified 10 candidates for repurposing in the treatment of fibrotic and 7 for degenerative diseases.
Access all drug discovery papers and probability of success in trials forecasts:
Access all drug discovery papers and probability of success in trials forecasts:
Drug Discovery Landscape
0 orphan drug designations.
0 orphan drug designations.
Let's accelerate rare disease drug discovery
Let's accelerate drug discovery
Get access to Explority AI’s forecasts to outperform average preclinical success rates. Whether you’re expanding your R&D pipeline, evaluating a partnership, or simply have a question — we’d love to hear from you.